Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional Results available

Subcutaneous Treatment In Randomized Subjects To Evaluate Safety And Efficacy In Generalized Lupus Erythematosus

ClinicalTrials.gov ID: NCT01405196

Public ClinicalTrials.gov record NCT01405196. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Nov 7, 2026, 3:26 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Double-blind, Randomized, Placebo-controlled, Multicenter Dose-ranging Study To Evaluate The Efficacy And Safety Of Pf-04236921 In Subjects With Systemic Lupus Erythematosus (Sle)

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The objective of this study is to evaluate and compare efficacy of 3 dose levels of PF-04236921 to placebo in subjects with generalized lupus using a measure called the Systemic Lupus Erythematosus (SLE) Responder Index. The study will evaluate secondary and exploratory measures as well.

Study identification

NCT ID
NCT01405196
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Pfizer
Industry
Enrollment
183 participants

Conditions and interventions

Interventions

Biological

Eligibility (public fields only)

Age range
18 Years to 75 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Dec 2011 (Actual)
Primary completion
Mar 2014 (Actual)
Completion
Mar 2014 (Actual)
Last update posted
Dec 19, 2017

2011 – 2014

United States locations

U.S. sites
68
U.S. states
22
U.S. cities
45
Facility City State ZIP Site status
Anniston Medical Clinic, PC Anniston Alabama 36207 —
Pinnacle Research Group, LLC Anniston Alabama 36207 —
Achieve Clinical Research, LLC Birmingham Alabama 35216 —
Med Investigations, Inc. Fair Oaks California 95628 —
Premier Clinical Research, LLC Lakewood California 90712 —
Novo Research Long Beach California 90813 —
St Mary Medical Center Long Beach California 90813 —
Cedars-Sinai Medical Center Los Angeles California 90048 —
Wallace Rheumatic Study Center Los Angeles California 90048 —
UCLA Division of Rheumatology Los Angeles California 90095-1670 —
UCLA Rheumatology Clinical Research Center Los Angeles California 90095-1670 —
Ronald Reagan UCLA Medical Center Los Angeles California 90095-6984 —
UCLA Medical Center Los Angeles California 90095 —
Inland Rheumatology and Osteoporosis Medical Group Upland California 91786 —
Inland Rheumatology Clinical Trials, Inc. Upland California 91786 —
Asthma, Allergy, Arthritis and Lung Center Daytona Beach Florida 32114 —
Southeastern Arthritis Center Gainesville Florida 32607 —
Southeastern Community Pharmacy Gainesville Florida 32607 —
Southeastern Integrated Medical, PL, d/b/a Florida Medical Research Institute Gainesville Florida 32607 —
Southeastern lmaging & Diagnostics Gainesville Florida 32607 —
New Horizon Research Center Miami Florida 33175 —
Arthritis Associates Orlando Florida 32804 —
Millennium Research Ormond Beach Florida 32174 —
The Arthritis Center Palm Harbor Florida 34684 —
Advent Clinical Research Centers, Inc. Pinellas Park Florida 33781 —
Burnette & Silverfield, MDS PLC Tampa Florida 33614 —
Emory University Atlanta Georgia 30303 —
Grady Health Systems Atlanta Georgia 30303 —
Idaho Arthritis Center Meridian Idaho 83642 —
University of Chicago Medical Center Chicago Illinois 60637 —
Beacon Medical Group Rheumatology Granger Indiana 46530 —
Indiana CTSI Clinical Research Center Indianapolis Indiana 46202 —
Investigational Drug Services Indianapolis Indiana 46202 —
Johns Hopkins University School of Medicine Baltimore Maryland 21205 —
Johns Hopkins Outpatient Center Baltimore Maryland 21287 —
Johns Hopkins Outpatient Express Testing Center Baltimore Maryland 21287 —
Tufts Medical Center/ Center for Arthritis and Rheumatic Diseases Boston Massachusetts 02111 —
University of Michigan Ann Arbor Michigan 48109-5008 —
University of Michigan Health System Ann Arbor Michigan 48109-5422 —
University of Michigan Health System, Ann Arbor Michigan 48109-5872 —
Henry Ford Health System (Henry Ford Medical Center) Detroit Michigan 48201-3450 —
Shores Rheumatology P.C Saint Clair Shores Michigan 48081 —
University of Nevada School of Medicine Las Vegas Nevada 89102 —
Albuquerque Clinical Trials Albuquerque New Mexico 87102 —
Arthritis and Osteoporosis Medical Associates, PLLC Brooklyn New York 11201 —
Feinstein Institute for Medical Research Manhasset New York 11030 —
NYU Center for Musculoskeletal Care New York New York 10016 —
Allergy/Immunology and Rheumatology Rochester New York 14623 —
The University of North Carolina Clinical and Translational Research Center Chapel Hill North Carolina 27514 —
The University of North Carolina Hospitals Investigational Drug Services Chapel Hill North Carolina 27514 —
The University of North Carolina at Chapel Hill Chapel Hill North Carolina 27599 —
Joint and Muscle Medical Care Charlotte North Carolina 28204 —
Box Arthritis & Rheumatology of the Carolinas, PLLC Charlotte North Carolina 28210 —
Cleveland Clinic Foundation Cleveland Ohio 44195 —
Paramount Medical Research and Consulting, LLC Middleburg Heights Ohio 44130 —
Oklahoma Medical Research Foundation Oklahoma City Oklahoma 73104 —
Clinical Research Center of Reading, LLP Wyomissing Pennsylvania 19610 —
Low Country Rheumatology, PA/Low Country Research Charleston South Carolina 29406 —
Arthritis Clinic Jackson Tennessee 38305 —
West Tennessee Research Institute Jackson Tennessee 38305 —
UT Southwestern Medical Center Dallas Texas 75390-8577 —
UT Southwestern Medical Center Dallas Texas 75390 —
Rheumatic Disease Clinical Research Center, LLC Houston Texas 77004 —
Accurate Clinical Research, Inc. Houston Texas 77034 —
Southwest Rheumatology Research, LLC Mesquite Texas 75150 —
The Seattle Arthritis Clinic Seattle Washington 98133 —
Tacoma Center for Arthritis Research, PS Tacoma Washington 98405 —
Mountain State Clinical Research Clarksburg West Virginia 26301 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 45 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01405196, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Dec 19, 2017 · Synced Nov 7, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT01405196 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →